儿童和青少年慢性髓性白血病:西印度的一项后续研究
Sangita A Vanik1, Dhaval Jetly1, Biren Parikh1
1Department of Oncopathology, The Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India.
Indian journal of pathology & microbiology
|August 2, 2023
概括
儿童和青少年慢性髓性白血病 (CML) 患者经常出现高白细胞 (WBC) 计数. 对氨酸激酶抑制剂 (TKI) 的治疗反应与这个年龄组的成人预后得分没有显著的相关性.
科学领域:
- 血液学 血液学 血液学
- 儿科瘤学 儿科瘤学
- 分子生物学分子生物学
背景情况:
- 慢性髓性白血病 (CML) 是儿科和青少年群体中罕见的血液性恶性瘤.
- 在年轻人中了解CML需要具体的临床和血液病理学评估.
研究的目的:
- 评估儿科/青少年CML的临床,血病学和生物化学参数.
- 评估对一线氨酸激酶抑制剂 (TKI) 的治疗反应.
- 为了将TKI反应与成人预后评分系统相关联.
主要方法:
- 对44个BCR-ABL1阳性儿科/青少年CML病例的回顾性分析.
- 使用医院软件评估临床和实验室数据.
- 监测治疗反应和应用预后评分系统.
主要成果:
- 患者的平均年龄为11.6岁,白细胞计数高 (63.6%>250,000/μL).
- 观察到完全血液学反应 (97.7%) 和分子反应 (78.1%) 的高率.
- 大多数患者的Sokal和EUTOS得分较低,CHR在3个月后达到75%.
结论:
- 儿科/青少年的CML病例通常呈现出高的白细胞计数.
- 预后评分系统显示,与治疗反应没有统计学上显著的关联.
- 需要进一步进行大规模的研究,以确定这一群体的TKI治疗反应.
相关概念视频
Bone Marrow Sampling and Transplants
360
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
360
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


